1. Home
  2. NKTR vs CIA Comparison

NKTR vs CIA Comparison

Compare NKTR & CIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • CIA
  • Stock Information
  • Founded
  • NKTR 1990
  • CIA 1969
  • Country
  • NKTR United States
  • CIA United States
  • Employees
  • NKTR N/A
  • CIA N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • CIA Life Insurance
  • Sector
  • NKTR Health Care
  • CIA Finance
  • Exchange
  • NKTR Nasdaq
  • CIA Nasdaq
  • Market Cap
  • NKTR 247.9M
  • CIA 222.9M
  • IPO Year
  • NKTR 1994
  • CIA N/A
  • Fundamental
  • Price
  • NKTR $1.01
  • CIA $4.80
  • Analyst Decision
  • NKTR Buy
  • CIA
  • Analyst Count
  • NKTR 4
  • CIA 0
  • Target Price
  • NKTR $4.00
  • CIA N/A
  • AVG Volume (30 Days)
  • NKTR 1.8M
  • CIA 97.6K
  • Earning Date
  • NKTR 11-07-2024
  • CIA 11-07-2024
  • Dividend Yield
  • NKTR N/A
  • CIA N/A
  • EPS Growth
  • NKTR N/A
  • CIA N/A
  • EPS
  • NKTR N/A
  • CIA 0.43
  • Revenue
  • NKTR $93,137,000.00
  • CIA $248,376,000.00
  • Revenue This Year
  • NKTR N/A
  • CIA N/A
  • Revenue Next Year
  • NKTR N/A
  • CIA $4.17
  • P/E Ratio
  • NKTR N/A
  • CIA $11.10
  • Revenue Growth
  • NKTR 5.53
  • CIA 3.02
  • 52 Week Low
  • NKTR $0.42
  • CIA $1.78
  • 52 Week High
  • NKTR $1.93
  • CIA $5.95
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 30.88
  • CIA 54.87
  • Support Level
  • NKTR $1.33
  • CIA $4.34
  • Resistance Level
  • NKTR $1.07
  • CIA $4.85
  • Average True Range (ATR)
  • NKTR 0.09
  • CIA 0.26
  • MACD
  • NKTR -0.04
  • CIA -0.03
  • Stochastic Oscillator
  • NKTR 6.26
  • CIA 51.49

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About CIA Citizens Inc. ($1.00 Par)

Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. the Company derives its revenues principally from life insurance premiums earned for insurance coverages provided to insureds in our two operating segments and net investment income. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment.

Share on Social Networks: